Abstract
Dihydropyrazole, a small bioactive molecule, is a prominent structural motif found in numerous pharmaceutically active compounds. The chiral dihydropyrazole structure has been demonstrated to bear important biological activities such as anticancer, antimicrobial, antimalarial, antinociceptive, antiviral, antitubercular, antiinflammatory, anticonvulsant and steroidal, and can also act as MAO inhibitors, CB1 receptor antagonists and nitric oxide synthase inhibitors. The review describes the latest advances in the synthesis of dihydropyrazole derivatives incorporating physiologically active substances. It is the first attempt at a general and systematic account of the extensive literature data on this subject.
Keywords: Dihydropyrazole, biological activities, SAR, lead, Cannabinoid Receptor 1, Monoamine Oxidase, Structure Activity Relationship, Human Promyelocytic Leukemia, Mouse Lymphoma, Human Prostate Cancer, Human Epidermoid Carcinoma Cancer, T Lymphocytic Leukemia, Human Gastric Cancer, Hman Lukemic Lmphoblasts, Human Myeloma, National Cancer Institute, Epidermal Growth Factor Receptor, Minimum Inhibitory Concentrations, Human Breast Adenocarcinoma, 3-(4,5-Dimethyl-2-Thiazyl)-2,5-Diphenyl-2H-Tetrazolium Bromide, Dimethyl Sulfoxide, Mueller-Hinton, Phosphate Buffered Saline, Enzymelinked Immunosorbentassy, Tlomere Rpeat Aplification Potocol
Mini-Reviews in Medicinal Chemistry
Title: Synthesis and Biological Activity of Chiral Dihydropyrazole: Potential Lead for Drug Design
Volume: 11 Issue: 9
Author(s): X.-H. Liu, B.-F. Ruan, J. Li, F.-H. Chen, B.-A. Song, H.-L. Zhu, P. S. Bhadury and J. Zhao
Affiliation:
Keywords: Dihydropyrazole, biological activities, SAR, lead, Cannabinoid Receptor 1, Monoamine Oxidase, Structure Activity Relationship, Human Promyelocytic Leukemia, Mouse Lymphoma, Human Prostate Cancer, Human Epidermoid Carcinoma Cancer, T Lymphocytic Leukemia, Human Gastric Cancer, Hman Lukemic Lmphoblasts, Human Myeloma, National Cancer Institute, Epidermal Growth Factor Receptor, Minimum Inhibitory Concentrations, Human Breast Adenocarcinoma, 3-(4,5-Dimethyl-2-Thiazyl)-2,5-Diphenyl-2H-Tetrazolium Bromide, Dimethyl Sulfoxide, Mueller-Hinton, Phosphate Buffered Saline, Enzymelinked Immunosorbentassy, Tlomere Rpeat Aplification Potocol
Abstract: Dihydropyrazole, a small bioactive molecule, is a prominent structural motif found in numerous pharmaceutically active compounds. The chiral dihydropyrazole structure has been demonstrated to bear important biological activities such as anticancer, antimicrobial, antimalarial, antinociceptive, antiviral, antitubercular, antiinflammatory, anticonvulsant and steroidal, and can also act as MAO inhibitors, CB1 receptor antagonists and nitric oxide synthase inhibitors. The review describes the latest advances in the synthesis of dihydropyrazole derivatives incorporating physiologically active substances. It is the first attempt at a general and systematic account of the extensive literature data on this subject.
Export Options
About this article
Cite this article as:
Liu X.-H., Ruan B.-F., Li J., Chen F.-H., Song B.-A., Zhu H.-L., S. Bhadury P. and Zhao J., Synthesis and Biological Activity of Chiral Dihydropyrazole: Potential Lead for Drug Design, Mini-Reviews in Medicinal Chemistry 2011; 11 (9) . https://dx.doi.org/10.2174/138955711796355285
DOI https://dx.doi.org/10.2174/138955711796355285 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Combining Drug and Immune Therapy: A Potential Solution to Drug Resistance and Challenges of HIV Vaccines?
Current HIV Research Chemokines and Malaria Infection
Current Immunology Reviews (Discontinued) Protein Conformational Pathology in Alzheimers and Other Neurodegenerative Diseases; New Targets for Therapy
Current Alzheimer Research Using Functional Neuroimaging to Investigate the Mechanisms of Action of Selective Serotonin Reuptake Inhibitors (SSRIs)
Current Pharmaceutical Design Postoperative Care of the Transplanted Patient
Current Cardiology Reviews Neurotrophic Factors in the Pathogenesis of Neurological Disorders with Mental Retardation in Children
Current Pediatric Reviews An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy A Role for Leptin in the Systemic Inflammatory Response Syndrome (SIRS) and in Immune Response, an Update
Current Medicinal Chemistry Autoimmune Diseases and Atherosclerosis: The Inflammatory Connection
Current Immunology Reviews (Discontinued) Dietary Assumption of Plant Polyphenols and Prevention of Allergy
Current Pharmaceutical Design Microbiota Regulation of Inflammatory Bowel Disease
Inflammation & Allergy - Drug Targets (Discontinued) Antivirals of Ethnomedicinal Origin: Structure-activity Relationship and Scope
Mini-Reviews in Medicinal Chemistry Cognitive Consequences of a Sustained Monocyte Type 1 IFN Response in HIV-1 Infection
Current HIV Research Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective
Central Nervous System Agents in Medicinal Chemistry Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
Current Alzheimer Research Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part II
Inflammation & Allergy - Drug Targets (Discontinued) mRNA as a Versatile Tool for Exogenous Protein Expression
Current Gene Therapy The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets